HIGHLIGHTS
- who: Heungjo Kim from the Department Yonsei University have published the paper: Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect, in the Journal: Scientific Reports Scientific Reports of May/31,/2020
- what: The authors investigated the additional effects of ARNI on blood glucose control, compared with those of ACEIs or ARBs.
- future: In the future long-term studies are needed as ARNI use increases to obtain more statistically significant results.
SUMMARY
The secondary outcomes were the difference between the two drug groups in reaching . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.